{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:53:57Z","timestamp":1790250837365,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zika virus (ZIKV) outbreak in Americas led to extensive efforts to develop vaccines and ZIKV-specific diagnostics. In the current study, we use whole genome phage display library spanning the entire ZIKV genome (ZIKV-GFPDL) for in-depth immune profiling of IgG and IgM antibody repertoires in serum and urine longitudinal samples from individuals acutely infected with ZIKV. We observe a very diverse IgM immune repertoire encompassing the entire ZIKV polyprotein on day 0 in both serum and urine. ZIKV-specific IgG antibodies increase 10-fold between day 0 and day 7 in serum, but not in urine; these are highly focused on prM\/E, NS1 and NS2B. Differential antibody affinity maturation is observed against ZIKV structural E protein compared with nonstructural protein NS1. Serum antibody affinity to ZIKV-E protein inversely correlates with ZIKV disease symptoms. Our study provides insight into unlinked evolution of immune response to ZIKV infection and identified unique targets for ZIKV serodiagnostics.<\/jats:p>","DOI":"10.1038\/s41467-019-09914-3","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T10:10:59Z","timestamp":1556273459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome"],"prefix":"10.1038","volume":"10","author":[{"given":"Supriya","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo F.","family":"Belaunzar\u00e1n-Zamudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ramos-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"N\u00e1jera-Cancino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Caballero-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla R.","family":"Navarro-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ruiz-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4879-4941","authenticated-orcid":false,"given":"John H.","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":false,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"9914_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med Hyg. 46, 509\u2013520 (1952).","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"key":"9914_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2016.2899","volume":"315","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M., Stringer, E. M. & de Silva, A. M. The emerging Zika virus epidemic in the Americas: research priorities. JAMA 315, 1945\u20131946 (2016).","journal-title":"JAMA"},{"key":"9914_CR3","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J. Virol. 90, 4864\u20134875 (2016).","journal-title":"J. Virol."},{"key":"9914_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3201\/eid2110.150847","volume":"21","author":"GS Campos","year":"2015","unstructured":"Campos, G. S., Bandeira, A. C. & Sardi, S. I. Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21, 1885\u20131886 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"9914_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med 374, 951\u2013958 (2016).","journal-title":"N. Engl. J. Med"},{"key":"9914_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"9914_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1126\/science.aaf5036","volume":"352","author":"NR Faria","year":"2016","unstructured":"Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345\u2013349 (2016).","journal-title":"Science"},{"key":"9914_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.immuni.2017.02.005","volume":"46","author":"DH Barouch","year":"2017","unstructured":"Barouch, D. H., Thomas, S. J. & Michael, N. L. Prospects for a Zika virus vaccine. Immunity 46, 176\u2013182 (2017).","journal-title":"Immunity"},{"key":"9914_CR9","unstructured":"Gaudinski, M. R. et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet\u00a0391, 552\u2013562\u00a0(2018)."},{"key":"9914_CR10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMp1607762","volume":"375","author":"HD Marston","year":"2016","unstructured":"Marston, H. D., Lurie, N., Borio, L. L. & Fauci, A. S. Considerations for developing a Zika virus vaccine. N. Engl. J. Med 375, 1209\u20131212 (2016).","journal-title":"N. Engl. J. Med"},{"key":"9914_CR11","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jix464","volume":"216","author":"KM Morabito","year":"2017","unstructured":"Morabito, K. M. & Graham, B. S. Zika virus vaccine development. J. Infect. Dis. 216, S957\u2013S963 (2017).","journal-title":"J. Infect. Dis."},{"key":"9914_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"9914_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMcibr1701402","volume":"376","author":"SJ Thomas","year":"2017","unstructured":"Thomas, S. J. Zika virus vaccines - a full field and looking for the closers. N. Engl. J. Med 376, 1883\u20131886 (2017).","journal-title":"N. Engl. J. Med"},{"key":"9914_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"9914_CR15","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","volume":"8","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci. Transl. Med. 8, 369ra179 (2016).","journal-title":"Sci. Transl. Med"},{"key":"9914_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443\u2013447 (2016).","journal-title":"Nature"},{"issue":"410","key":"9914_CR17","doi-asserted-by":"publisher","first-page":"eaan8184","DOI":"10.1126\/scitranslmed.aan8184","volume":"9","author":"Diogo M. Magnani","year":"2017","unstructured":"Magnani, D. M. et al. Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques. Sci Transl Med. 9, eaan8184, (2017).","journal-title":"Science Translational Medicine"},{"key":"9914_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","volume":"169","author":"DF Robbiani","year":"2017","unstructured":"Robbiani, D. F. et al. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169, 597\u2013609 e511 (2017).","journal-title":"Cell"},{"key":"9914_CR19","volume":"6","author":"Y Wu","year":"2017","unstructured":"Wu, Y. et al. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. Emerg. Microbes Infect. 6, e89 (2017).","journal-title":"Emerg. Microbes Infect."},{"key":"9914_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"RS Lanciotti","year":"2008","unstructured":"Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232\u20131239 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"9914_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso, D. & Gubler, D. J. Zika virus. Clin. Microbiol Rev. 29, 487\u2013524 (2016).","journal-title":"Clin. Microbiol Rev."},{"key":"9914_CR22","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/infdis\/jiw477","volume":"214","author":"MT Cordeiro","year":"2016","unstructured":"Cordeiro, M. T. et al. Results of a Zika virus (ZIKV) immunoglobulin M-specific diagnostic assay are highly correlated with detection of neutralizing anti-ZIKV antibodies in neonates with congenital disease. J. Infect. Dis. 214, 1897\u20131904 (2016).","journal-title":"J. Infect. Dis."},{"key":"9914_CR23","doi-asserted-by":"publisher","first-page":"e1000049","DOI":"10.1371\/journal.pmed.1000049","volume":"6","author":"S Khurana","year":"2009","unstructured":"Khurana, S. et al. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 6, e1000049 (2009).","journal-title":"PLoS Med."},{"key":"9914_CR24","doi-asserted-by":"publisher","first-page":"e1005554","DOI":"10.1371\/journal.ppat.1005554","volume":"12","author":"S Fuentes","year":"2016","unstructured":"Fuentes, S., Coyle, E. M., Beeler, J., Golding, H. & Khurana, S. Antigenic fingerprinting following primary RSV infection in young children identifies novel antigenic sites and reveals unlinked evolution of human antibody repertoires to fusion and attachment glycoproteins. PLoS Pathog. 12, e1005554 (2016).","journal-title":"PLoS Pathog."},{"key":"9914_CR25","doi-asserted-by":"publisher","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","volume":"3","author":"S Khurana","year":"2011","unstructured":"Khurana, S. et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 3, 85ra48 (2011).","journal-title":"Sci. Transl. Med"},{"key":"9914_CR26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm.4201","volume":"22","author":"S Khurana","year":"2016","unstructured":"Khurana, S. et al. Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies. Nat. Med. 22, 1439\u20131447 (2016).","journal-title":"Nat. Med."},{"key":"9914_CR27","first-page":"15ra15","volume":"2","author":"S Khurana","year":"2010","unstructured":"Khurana, S. et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza. Virus Sci. Transl. Med. 2, 15ra15 (2010).","journal-title":"Virus Sci. Transl. Med."},{"key":"9914_CR28","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1128\/JVI.07085-11","volume":"86","author":"N Verma","year":"2012","unstructured":"Verma, N. et al. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. J. Virol. 86, 5515\u20135522 (2012).","journal-title":"J. Virol."},{"key":"9914_CR29","doi-asserted-by":"publisher","first-page":"12455","DOI":"10.1128\/JVI.06023-11","volume":"85","author":"S Khurana","year":"2011","unstructured":"Khurana, S. et al. H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance. J. Virol. 85, 12455\u201312463 (2011).","journal-title":"J. Virol."},{"key":"9914_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.qai.0000242465.50947.5f","volume":"43","author":"S Khurana","year":"2006","unstructured":"Khurana, S. et al. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. J. Acquir Immune Defic. Syndr. 43, 304\u2013312 (2006).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"9914_CR31","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1128\/JVI.80.5.2092-2099.2006","volume":"80","author":"S Khurana","year":"2006","unstructured":"Khurana, S. et al. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. J. Virol. 80, 2092\u20132099 (2006).","journal-title":"J. Virol."},{"key":"9914_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027 (2016).","journal-title":"Cell"},{"key":"9914_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4269\/ajtmh.14-0145","volume":"91","author":"IY Amaya-Larios","year":"2014","unstructured":"Amaya-Larios, I. Y. et al. Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, Mexico. Am. J. Trop. Med Hyg. 91, 1057\u20131065 (2014).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"9914_CR34","doi-asserted-by":"publisher","first-page":"eaan1589","DOI":"10.1126\/scitranslmed.aan1589","volume":"9","author":"I Bosch","year":"2017","unstructured":"Bosch, I. et al. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci. Transl. Med 9, eaan1589 (2017).","journal-title":"Sci. Transl. Med"},{"key":"9914_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P. et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132 (2016).","journal-title":"Science"},{"key":"9914_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478 (2016).","journal-title":"Nature"},{"key":"9914_CR37","doi-asserted-by":"publisher","first-page":"eaao4163","DOI":"10.1126\/scitranslmed.aao4163","volume":"9","author":"P Abbink","year":"2017","unstructured":"Abbink, P. et al. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci. Transl. Med. 9, eaao4163 (2017).","journal-title":"Sci. Transl. Med"},{"key":"9914_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3201\/eid2101.140894","volume":"21","author":"AC Gourinat","year":"2015","unstructured":"Gourinat, A. C., O\u2019Connor, O., Calvez, E., Goarant, C. & Dupont-Rouzeyrol, M. Detection of Zika virus in urine. Emerg. Infect. Dis. 21, 84\u201386 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"9914_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22102-5","volume":"8","author":"LE Lamb","year":"2018","unstructured":"Lamb, L. E. et al. Rapid detection of Zika virus in urine samples and infected mosquitos by reverse transcription-loop-mediated isothermal amplification. Sci. Rep. 8, 3803 (2018).","journal-title":"Sci. Rep."},{"key":"9914_CR40","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMoa1613108","volume":"379","author":"G Paz-Bailey","year":"2018","unstructured":"Paz-Bailey, G. et al. Persistence of Zika virus in body fluids - final report. N. Engl. J. Med 379, 1234\u20131243 (2018).","journal-title":"N. Engl. J. Med"},{"key":"9914_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva, N. S. & Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15, 137\u2013148 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"9914_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"9914_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu Rev. Immunol."},{"key":"9914_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2016.12.004","volume":"45","author":"O Bannard","year":"2017","unstructured":"Bannard, O. & Cyster, J. G. Germinal centers: programmed for affinity maturation and antibody diversification. Curr. Opin. Immunol. 45, 21\u201330 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"9914_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","volume":"98","author":"DA Muller","year":"2013","unstructured":"Muller, D. A. & Young, P. R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antivir. Res. 98, 192\u2013208 (2013).","journal-title":"Antivir. Res"},{"key":"9914_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"DL Akey","year":"2014","unstructured":"Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881\u2013885 (2014).","journal-title":"Science"},{"key":"9914_CR47","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.1038\/nmicrobiol.2016.87","volume":"1","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat. Microbiol. 1, 16087 (2016).","journal-title":"Nat. Microbiol"},{"key":"9914_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coi.2014.02.010","volume":"28","author":"GD Victora","year":"2014","unstructured":"Victora, G. D. & Mesin, L. Clonal and cellular dynamics in germinal centers. Curr. Opin. Immunol. 28, 90\u201396 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"9914_CR49","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696\u2013704 (2016).","journal-title":"Cell Host Microbe"},{"key":"9914_CR50","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1128\/JCM.00548-13","volume":"51","author":"JJ Waggoner","year":"2013","unstructured":"Waggoner, J. J. et al. Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J. Clin. Microbiol. 51, 2172\u20132181 (2013).","journal-title":"J. Clin. Microbiol"},{"key":"9914_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1743-422X-10-58","volume":"10","author":"P Patel","year":"2013","unstructured":"Patel, P. et al. Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol. J. 10, 58 (2013).","journal-title":"Virol. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09914-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:02:28Z","timestamp":1671231748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09914-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9914"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09914-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1943"}}